AU2011332187B2 - User-activated self-contained co-packaged iontophoretic drug delivery system - Google Patents

User-activated self-contained co-packaged iontophoretic drug delivery system Download PDF

Info

Publication number
AU2011332187B2
AU2011332187B2 AU2011332187A AU2011332187A AU2011332187B2 AU 2011332187 B2 AU2011332187 B2 AU 2011332187B2 AU 2011332187 A AU2011332187 A AU 2011332187A AU 2011332187 A AU2011332187 A AU 2011332187A AU 2011332187 B2 AU2011332187 B2 AU 2011332187B2
Authority
AU
Australia
Prior art keywords
electrode
conductive
conductive medium
drug delivery
delivery system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011332187A
Other languages
English (en)
Other versions
AU2011332187A1 (en
Inventor
Terri B. Sebree
Robert P. Stathopulos
Mihai A. Vinatoru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals International GmbH
Original Assignee
Teva Pharmaceuticals International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceuticals International GmbH filed Critical Teva Pharmaceuticals International GmbH
Publication of AU2011332187A1 publication Critical patent/AU2011332187A1/en
Assigned to TEVA PHARMACEUTICALS INTERNATIONAL GMBH reassignment TEVA PHARMACEUTICALS INTERNATIONAL GMBH Request for Assignment Assignors: NUPATHE, INC.
Application granted granted Critical
Publication of AU2011332187B2 publication Critical patent/AU2011332187B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2011332187A 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system Ceased AU2011332187B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41662310P 2010-11-23 2010-11-23
US61/416,623 2010-11-23
PCT/US2011/059981 WO2012071175A1 (en) 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system

Publications (2)

Publication Number Publication Date
AU2011332187A1 AU2011332187A1 (en) 2013-05-02
AU2011332187B2 true AU2011332187B2 (en) 2016-03-03

Family

ID=45044724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011332187A Ceased AU2011332187B2 (en) 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system

Country Status (12)

Country Link
US (1) US9327114B2 (enExample)
EP (1) EP2643048A1 (enExample)
JP (1) JP2013543773A (enExample)
CN (1) CN103228318B (enExample)
AU (1) AU2011332187B2 (enExample)
BR (1) BR112013012117A8 (enExample)
CA (1) CA2817824A1 (enExample)
EA (1) EA026254B1 (enExample)
IL (1) IL226067A0 (enExample)
MX (1) MX336812B (enExample)
NZ (1) NZ610305A (enExample)
WO (1) WO2012071175A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2817824A1 (en) 2010-11-23 2012-05-31 Nupathe, Inc. User-activated self-contained co-packaged iontophoretic drug delivery system
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
CA2916183C (en) 2013-07-03 2022-03-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with electronic component
EP2886153A1 (de) 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
JP6573913B2 (ja) 2014-05-20 2019-09-11 エルテーエス ローマン テラピー−ジステーメ アーゲー ロチゴチンを含む経皮送達システム
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
JP2016002368A (ja) * 2014-06-18 2016-01-12 日本電信電話株式会社 経皮薬物送達システム
WO2018006069A1 (en) 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
FR3152229A1 (fr) * 2023-08-25 2025-02-28 Feeligreen Dispositif de traitement de la peau

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817044A (en) * 1992-11-05 1998-10-06 Becton Dickenson And Company User activated iontophoertic device
US20090005824A1 (en) * 2007-06-29 2009-01-01 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
WO2010078313A1 (en) * 2008-12-30 2010-07-08 Nupathe, Inc. Electronic control of drug delivery system

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US5042975A (en) 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4917676A (en) 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
DE3903794A1 (de) 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
US5499967A (en) 1992-02-27 1996-03-19 Societe Anonyme Dite: Laboratoires D'hygiene Societe Anonyme Dite: Et De Dietetique (L.H.D.) Transdermal drug delivery device with waveshape generator
FR2688106B1 (fr) 1992-02-27 1994-09-09 Lhd Lab Hygiene Dietetique Dispositif de generation d'une tension electrique de forme d'onde predeterminee, appareil ionophoretique d'administration transdermique de medicaments.
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
US5445609A (en) 1993-05-28 1995-08-29 Alza Corporation Electrotransport agent delivery device having a disposable component and a removable liner
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
JPH08155041A (ja) 1994-12-05 1996-06-18 Advance Co Ltd イオントフォレシス用新規高能率電極システム
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
CN1170360A (zh) 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US5879322A (en) 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
ZA964320B (en) 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5983130A (en) 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
KR100281171B1 (ko) 1995-08-31 2001-03-02 나까도미 히로다카 이온토포레시스장치 및 그 전류제어방법
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5738647A (en) 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
US20010009983A1 (en) 1997-09-29 2001-07-26 Drug Delivery Technologies, Inc. Methods for implementing current delivery profiles used in an iontophoretic system
AU1997699A (en) 1997-12-16 1999-07-05 Alza Corporation Regulator with artificial load to maintain regulated delivery
JP4362012B2 (ja) 1997-12-17 2009-11-11 アルザ・コーポレーション 電流がプログラム調整されたイオン導入法
EP1170029B1 (en) 1999-04-12 2009-03-11 Hisamitsu Pharmaceutical Co., Inc. Device for iontophoresis
US6385488B1 (en) 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6377848B1 (en) 1999-08-25 2002-04-23 Vyteris, Inc. Devices activating an iontophoretic delivery device
EP1435945B1 (en) 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
EP1893278A2 (en) 2005-06-03 2008-03-05 Trans-Dermal Patents Company, LLC Agent delivery system
CA2817824A1 (en) 2010-11-23 2012-05-31 Nupathe, Inc. User-activated self-contained co-packaged iontophoretic drug delivery system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817044A (en) * 1992-11-05 1998-10-06 Becton Dickenson And Company User activated iontophoertic device
US20090005824A1 (en) * 2007-06-29 2009-01-01 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
WO2010078313A1 (en) * 2008-12-30 2010-07-08 Nupathe, Inc. Electronic control of drug delivery system

Also Published As

Publication number Publication date
CA2817824A1 (en) 2012-05-31
CN103228318B (zh) 2016-03-23
BR112013012117A2 (pt) 2016-09-27
CN103228318A (zh) 2013-07-31
US9327114B2 (en) 2016-05-03
WO2012071175A1 (en) 2012-05-31
IL226067A0 (en) 2013-06-27
EA201390745A1 (ru) 2014-01-30
EA026254B1 (ru) 2017-03-31
EP2643048A1 (en) 2013-10-02
NZ610305A (en) 2015-10-30
MX336812B (es) 2016-02-02
US20130296766A1 (en) 2013-11-07
MX2013005430A (es) 2013-07-05
JP2013543773A (ja) 2013-12-09
BR112013012117A8 (pt) 2017-10-10
AU2011332187A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
AU2011332187B2 (en) User-activated self-contained co-packaged iontophoretic drug delivery system
JP4361020B2 (ja) イオントフォレシス薬物送達システム
US10780266B2 (en) System and method for biphasic transdermal iontophoretic therapeutic agents
JP4154017B2 (ja) イオントフォレーシス装置および薬物ユニット
US9421356B2 (en) Transdermal methods and systems for the delivery of corticosteroid compounds
CA2229185C (en) Plaster structure for iontophoresis
CN102065807B (zh) 用于曲坦类化合物离子电渗疗法的多胺增强制剂
US5919156A (en) Iontophoretic drug delivery system, including unit for dispensing patches
US20070078373A1 (en) Pulsatile delivery of gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch
WO2015053879A1 (en) Sphingosine-1-phosphate receptor agonist iontophoretic devices and methods of using the same
KR20080110980A (ko) 이온토포레시스 장치 및 이온토포레시스 장치용 전원장치

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: TEVA PHARMACEUTICALS INTERNATIONAL GMBH

Free format text: FORMER APPLICANT(S): NUPATHE, INC.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired